Jennison Associates
LEGN icon

Jennison Associates’s Legend Biotech LEGN Stock Holding History

Jennison Associates’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-321,388
Closed -$9.05M – 706
2020
Q4 		$9.05M Buy
321,388
+186,031
+137% +$5.35M 0.01% 417
2020
Q3 		$4.18M Buy
135,357
+357
+0.3% +$12K ﹤0.01% 451
2020
Q2 		$5.75M Buy
+135,000
New +$5.27M 0.01% 420

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Jennison Associates's LEGN Position: Q1 2021 in Review

Jennison Associates sold out of Legend Biotech (LEGN) in Q1 2021, closing a stake of 321,388 shares — an estimated $9.05M sold.

Jennison Associates first reported a position in LEGN in Q2 2020 and held it in 3 quarters. The position peaked at $9.05M in Q4 2020. 71 funds tracked by Wall St. Rank hold LEGN as of Q1 2021.

  • Jennison Associates reported no remaining Legend Biotech position as of Q1 2021 after selling out during the quarter.
  • Jennison Associates sold 321,388 Legend Biotech shares in Q1 2021, an estimated $9.05M.
  • Jennison Associates first reported a position in Legend Biotech in Q2 2020 and held it in 3 quarters.
  • Jennison Associates's Legend Biotech position peaked at $9.05M in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2021.

Based on Jennison Associates's 13F filing for Q1 2021, filed 11 May 2021.